BioRestorative Therapies (BRTX) Net Margin (QoQ) (2012 - 2025)
BioRestorative Therapies (BRTX) Net Margin (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioRestorative Therapies | 1.98 Mn | -975,336.04 | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.33 Mn |
| Sep 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | -533,333.00 |
| Sep 30, 2024 | 179,475.00 |
| Jun 30, 2024 | 933,742.00 |
| Mar 31, 2024 | 479,356.00 |
| Dec 31, 2023 | -673,970.00 |
| Sep 30, 2023 | -529,788.00 |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | 10.90 Mn |
| Dec 31, 2022 | -11.16 Mn |
| Sep 30, 2022 | -947,088.00 |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 4.91 Mn |
| Dec 31, 2021 | -2.87 Mn |
| Sep 30, 2021 | -2.47 Mn |
| Jun 30, 2021 | 5.63 Mn |
| Mar 31, 2021 | -7.73 Mn |